This study is evaluating the safety and immune response generated by an investigational bivalent COVID-19 vaccine as a primary 3-dose series plus booster in healthy infants and children under 5 who have not previously been vaccinated for COVID-19.
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Working Hours
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)